• Consensus Rating: Hold
  • Consensus Price Target: $817.86
  • Forecasted Upside: 7,182.79%
  • Number of Analysts: 6
  • Breakdown:
  • 0 Sell Ratings
  • 5 Hold Ratings
  • 1 Buy Ratings
  • 0 Strong Buy Ratings
$11.23
▼ -0.09 (-0.80%)

This chart shows the closing price for AVVIY by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Aviva Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for AVVIY and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for AVVIY

Analyst Price Target is $817.86
▲ +7,182.79% Upside Potential
This price target is based on 6 analysts offering 12 month price targets for Aviva in the last 3 months. The average price target is $817.86, with a high forecast of $2,675.00 and a low forecast of $460.00. The average price target represents a 7,182.79% upside from the last price of $11.23.

This chart shows the closing price for AVVIY for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Hold

The current consensus among 6 contributing investment analysts is to hold stock in Aviva. This Hold consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 6 buy ratings
  • 6 hold ratings
  • 1 sell ratings
8/8/2021
  • 0 strong buy ratings
  • 6 buy ratings
  • 6 hold ratings
  • 1 sell ratings
11/6/2021
  • 0 strong buy ratings
  • 6 buy ratings
  • 6 hold ratings
  • 1 sell ratings
2/4/2022
  • 0 strong buy ratings
  • 3 buy ratings
  • 4 hold ratings
  • 1 sell ratings
5/5/2022
  • 0 strong buy ratings
  • 2 buy ratings
  • 5 hold ratings
  • 0 sell ratings
8/3/2022
  • 0 strong buy ratings
  • 1 buy ratings
  • 4 hold ratings
  • 0 sell ratings
11/1/2022
  • 0 strong buy ratings
  • 1 buy ratings
  • 4 hold ratings
  • 0 sell ratings
12/31/2022
  • 0 strong buy ratings
  • 1 buy ratings
  • 5 hold ratings
  • 0 sell ratings
1/30/2023

Latest Recommendations

  • 0 strong buy ratings
  • 1 buy ratings
  • 5 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
1/10/2023Deutsche Bank AktiengesellschaftBoost TargetGBX 485 ➝ GBX 540
1/4/2023Sanford C. BernsteinDowngradeOutperform ➝ Market Perform
12/15/2022InvestecDowngradeBuy ➝ Hold
11/22/2022BarclaysBoost TargetGBX 564 ➝ GBX 565
11/10/2022JPMorgan Chase & Co.Boost TargetGBX 510 ➝ GBX 535
10/27/2022Deutsche Bank AktiengesellschaftLower TargetGBX 520 ➝ GBX 485
10/21/2022JPMorgan Chase & Co.Lower TargetGBX 530 ➝ GBX 510
9/12/2022Deutsche Bank AktiengesellschaftBoost TargetGBX 490 ➝ GBX 520
8/30/2022BarclaysBoost TargetGBX 553 ➝ GBX 555
8/15/2022Credit Suisse GroupBoost TargetGBX 455 ➝ GBX 480
7/29/2022Morgan StanleyLower TargetGBX 2,700 ➝ GBX 2,675
7/28/2022Deutsche Bank AktiengesellschaftLower TargetGBX 520 ➝ GBX 490
7/13/2022CitigroupDowngradeBuy ➝ Neutral
6/14/2022InvestecUpgradeHold ➝ Buy
5/26/2022Credit Suisse GroupBoost TargetGBX 494 ➝ GBX 500
5/17/2022JPMorgan Chase & Co.Lower TargetGBX 530 ➝ GBX 520
5/15/2022The Goldman Sachs GroupDowngradeBuy ➝ Neutral
4/4/2022BarclaysDowngradeOverweight ➝ Equal Weight$480.00
3/28/2022UBS GroupUpgradeNeutral ➝ Buy
3/16/2022Deutsche Bank AktiengesellschaftLower TargetGBX 530 ➝ GBX 520
3/16/2022Royal Bank of CanadaBoost TargetGBX 450 ➝ GBX 470
2/16/2022UBS GroupBoost TargetGBX 420 ➝ GBX 460
1/18/2022InvestecDowngradeBuy ➝ Hold
9/10/2021BarclaysReiterated RatingOverweight
8/16/2021Morgan StanleyReiterated RatingEqual Weight
8/13/2021JPMorgan Chase & Co.Reiterated RatingOverweight
7/23/2021Exane BNP ParibasDowngradeNeutral ➝ Underperform
7/21/2021Morgan StanleyDowngradeOverweight ➝ Equal Weight
7/16/2021BarclaysReiterated RatingOverweight
7/15/2021JPMorgan Chase & Co.Reiterated RatingOverweight
7/1/2021Credit Suisse GroupReiterated RatingOutperform
6/7/2021The Goldman Sachs GroupInitiated CoverageBuy
5/20/2021Morgan StanleyReiterated RatingOverweight
5/18/2021BarclaysUpgradeEqual Weight ➝ Overweight
4/13/2021InvestecUpgradeBuy
4/12/2021Deutsche Bank AktiengesellschaftReiterated RatingBuy
3/30/2021BarclaysReiterated RatingEqual Weight
3/30/2021Morgan StanleyReiterated RatingOverweight
3/25/2021Berenberg BankUpgradeHold ➝ Buy
3/22/2021Royal Bank of CanadaReiterated RatingOutperform
3/11/2021Jefferies Financial GroupDowngradeBuy ➝ Hold
3/5/2021JPMorgan Chase & Co.Reiterated RatingOverweight
2/25/2021Morgan StanleyReiterated RatingOverweight
2/22/2021Bank of AmericaUpgradeNeutral ➝ Buy
2/18/2021CitigroupUpgradeNeutral ➝ Buy
2/5/2021Exane BNP ParibasDowngradeOutperform ➝ Neutral
2/3/2021Morgan StanleyUpgradeEqual Weight ➝ Overweight
2/2/2021JPMorgan Chase & Co.Reiterated RatingOverweight
1/29/2021BarclaysReiterated RatingEqual Weight
1/6/2021Deutsche Bank AktiengesellschaftReiterated RatingBuy
12/9/2020BarclaysReiterated RatingEqual Weight
11/27/2020Morgan StanleyReiterated RatingEqual Weight
11/27/2020Berenberg BankReiterated RatingHold
11/24/2020BarclaysReiterated RatingEqual Weight
9/28/2020Deutsche Bank AktiengesellschaftUpgradeHold ➝ Buy
9/25/2020Morgan StanleyReiterated RatingEqual Weight
9/8/2020BarclaysReiterated RatingEqual Weight
8/12/2020Morgan StanleyReiterated RatingEqual Weight
7/30/2020Royal Bank of CanadaReiterated RatingOutperform
7/10/2020JPMorgan Chase & Co.Reiterated RatingNeutral
6/23/2020Berenberg BankInitiated CoverageHold
6/10/2020UBS GroupReiterated RatingBuy
5/27/2020The Goldman Sachs GroupDowngradeConviction-Buy ➝ Buy
5/26/2020Deutsche Bank AktiengesellschaftReiterated RatingHold
4/23/2020Deutsche Bank AktiengesellschaftReiterated RatingHold
4/21/2020JPMorgan Chase & Co.Reiterated RatingNeutral
12/4/2019BarclaysDowngradeOverweight ➝ Equal Weight
11/26/2019CitigroupDowngradeBuy ➝ Neutral
11/22/2019JPMorgan Chase & Co.DowngradeOverweight ➝ Neutral
11/20/2019Deutsche Bank AktiengesellschaftDowngradeBuy ➝ Hold
10/17/2019InvestecUpgradeAdd ➝ Buy
12/11/2018Royal Bank of CanadaUpgradeOutperform ➝ Top Pick
9/13/2018InvestecInitiated Coverageadd
2/14/2018The Goldman Sachs GroupUpgradeNeutral ➝ Buy
(Data available from 1/31/2018 forward)

News Sentiment Rating

1.85 (Strong Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 1 very positive mentions
  • 2 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
7/5/2022
  • 1 very positive mentions
  • 6 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
8/4/2022
  • 5 very positive mentions
  • 10 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
9/3/2022
  • 3 very positive mentions
  • 9 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
10/3/2022
  • 3 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
11/2/2022
  • 1 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
12/2/2022
  • 1 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
1/1/2023
  • 1 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
1/31/2023

Current Sentiment

  • 1 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

  • No positive mentions tracked during this time.

Very Positive

Aviva logo
Aviva Plc is a holding company, which engages in the provision of long-term insurance and savings, general and health insurance, and fund management products and services. It operates through the following segments: United Kingdom and Ireland; Canada; France; Italy; Poland; and Other. The United Kingdom and Ireland segment offers risks associated with motor vehicles, property and liability, and medical expenses insurance cover to individuals and businesses. The Canada segment refers to the personal and commercial lines insurance products distributed through insurance brokers. The France segment consists of long-term and general insurance businesses. The Italy segment provides savings, investments, pension, and protection products to the life and non-domestic insurance markets. The Poland segment comprises of long-term business and general insurance business in Lithuania. The Other segment includes the long-term business operations in China, India, and Singapore; and life operations in Turkey. The company is headquartered in London, the United Kingdom.
Read More

Today's Range

Now: $11.23
Low: $11.22
High: $11.27

50 Day Range

MA: $10.86
Low: $10.60
High: $11.32

52 Week Range

Now: $11.23
Low: $8.05
High: $15.96

Volume

12,168 shs

Average Volume

25,869 shs

Market Capitalization

$15.77 billion

P/E Ratio

N/A

Dividend Yield

5.84%

Beta

1.2

Frequently Asked Questions

What sell-side analysts currently cover shares of Aviva?

The following Wall Street sell-side analysts have issued reports on Aviva in the last twelve months: Barclays PLC, Citigroup Inc., Credit Suisse Group AG, Deutsche Bank Aktiengesellschaft, Investec, JPMorgan Chase & Co., Morgan Stanley, Royal Bank of Canada, Sanford C. Bernstein, The Goldman Sachs Group, Inc., and UBS Group AG.
View the latest analyst ratings for AVVIY.

What is the current price target for Aviva?

7 Wall Street analysts have set twelve-month price targets for Aviva in the last year. Their average twelve-month price target is $817.86, suggesting a possible upside of 7,182.8%. Morgan Stanley has the highest price target set, predicting AVVIY will reach $2,675.00 in the next twelve months. UBS Group AG has the lowest price target set, forecasting a price of $460.00 for Aviva in the next year.
View the latest price targets for AVVIY.

What is the current consensus analyst rating for Aviva?

Aviva currently has 5 hold ratings and 1 buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in AVVIY, but not buy more shares or sell existing shares.
View the latest ratings for AVVIY.

What other companies compete with Aviva?

How do I contact Aviva's investor relations team?

Aviva's physical mailing address is ST HELENS 1 UNDERSHAFT, LONDON X0, EC3P 3DQ. The financial services provider's listed phone number is 442072832000 and its investor relations email address is [email protected] The official website for Aviva is www.aviva.com. Learn More about contacing Aviva investor relations.